Migraine nasal spray from Pfizer snags FDA approval for expected summer launch
People suffering from migraines will soon have access to pain relief in the form of a nasal Food and Drug Administration (FDA) has approved the first calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray intended to treat migraines…
Read More